Ed
👤 SpeakerAppearances Over Time
Podcast Appearances
So we need more price transparency, which, by the way, Biden worked on, and actually Trump worked on a little bit too, but we haven't really seen that come to any fruition. And then we need Medicare to be able to have the ability to negotiate on prices, which is what every other country has, and we don't have it for some reason. Again, Biden...
changed that in the Inflation Reduction Act, but we still haven't seen really any reduction in the price of drugs, I think because it hasn't been properly enforced. And the last thing I will say, I looked back at our conversation with Jonathan Cantor, who's the previous head of the antitrust division of the DOJ,
changed that in the Inflation Reduction Act, but we still haven't seen really any reduction in the price of drugs, I think because it hasn't been properly enforced. And the last thing I will say, I looked back at our conversation with Jonathan Cantor, who's the previous head of the antitrust division of the DOJ,
changed that in the Inflation Reduction Act, but we still haven't seen really any reduction in the price of drugs, I think because it hasn't been properly enforced. And the last thing I will say, I looked back at our conversation with Jonathan Cantor, who's the previous head of the antitrust division of the DOJ,
And we asked him the question, what is the one industry that most needs regulation and increased regulatory enforcement, specifically from an antitrust perspective? And his number one answer was healthcare.
And we asked him the question, what is the one industry that most needs regulation and increased regulatory enforcement, specifically from an antitrust perspective? And his number one answer was healthcare.
And we asked him the question, what is the one industry that most needs regulation and increased regulatory enforcement, specifically from an antitrust perspective? And his number one answer was healthcare.
He talked about a company like UnitedHealth is placing itself on both sides of the trade in a lot of cases where they're offering the insurance, but then they're also a pharmacy benefit manager at the same time. So they're sort of buying and selling from itself. But I think it was really interesting that he said that. And I hope that what we will see is some increase in regulating this industry.
He talked about a company like UnitedHealth is placing itself on both sides of the trade in a lot of cases where they're offering the insurance, but then they're also a pharmacy benefit manager at the same time. So they're sort of buying and selling from itself. But I think it was really interesting that he said that. And I hope that what we will see is some increase in regulating this industry.
He talked about a company like UnitedHealth is placing itself on both sides of the trade in a lot of cases where they're offering the insurance, but then they're also a pharmacy benefit manager at the same time. So they're sort of buying and selling from itself. But I think it was really interesting that he said that. And I hope that what we will see is some increase in regulating this industry.
But again, I don't see this as totally structural yet because I still look at the money in lobbying and the fact that it's $300 million last year that was spent on healthcare lobbying. I just, I'm not that optimistic at a structural level.
But again, I don't see this as totally structural yet because I still look at the money in lobbying and the fact that it's $300 million last year that was spent on healthcare lobbying. I just, I'm not that optimistic at a structural level.
But again, I don't see this as totally structural yet because I still look at the money in lobbying and the fact that it's $300 million last year that was spent on healthcare lobbying. I just, I'm not that optimistic at a structural level.
I would encourage everyone to go look at Senate Bill 3548, which was supposed to address all of this, and it was actually backed by both sides. And you look at what happened, it was proposed, and now suddenly it's just dead. And you try to ask the question, what happened to the bill?
I would encourage everyone to go look at Senate Bill 3548, which was supposed to address all of this, and it was actually backed by both sides. And you look at what happened, it was proposed, and now suddenly it's just dead. And you try to ask the question, what happened to the bill?
I would encourage everyone to go look at Senate Bill 3548, which was supposed to address all of this, and it was actually backed by both sides. And you look at what happened, it was proposed, and now suddenly it's just dead. And you try to ask the question, what happened to the bill?
And everyone says, oh, it just sort of didn't get reviewed, and it just got kind of held up in Congress, and so now it's dead. It's unbelievable. how you just see this happen, how the money in politics actually does just grind these things to a halt. And then you don't really know it because it's such a soft and unceremonious death. Like you sort of forget about the issue.
And everyone says, oh, it just sort of didn't get reviewed, and it just got kind of held up in Congress, and so now it's dead. It's unbelievable. how you just see this happen, how the money in politics actually does just grind these things to a halt. And then you don't really know it because it's such a soft and unceremonious death. Like you sort of forget about the issue.
And everyone says, oh, it just sort of didn't get reviewed, and it just got kind of held up in Congress, and so now it's dead. It's unbelievable. how you just see this happen, how the money in politics actually does just grind these things to a halt. And then you don't really know it because it's such a soft and unceremonious death. Like you sort of forget about the issue.
But go look up that bill because that addresses everything we're talking about, price negotiations, price transparency. And I just sort of flopped in Congress. Let's move on. very different vibe. HBO is doing another rebrand, their fifth rebrand in five years. We had HBO Go, then HBO Now, then HBO Max, then Max, and we are back to HBO Max.